Chemours (CC) Current Deferred Revenue (2016 - 2021)
Historic Current Deferred Revenue for Chemours (CC) over the last 7 years, with Q4 2021 value amounting to $3.0 million.
- Chemours' Current Deferred Revenue fell 5714.29% to $3.0 million in Q4 2021 from the same period last year, while for Dec 2021 it was $3.0 million, marking a year-over-year decrease of 5714.29%. This contributed to the annual value of $3.0 million for FY2021, which is 5714.29% down from last year.
- Latest data reveals that Chemours reported Current Deferred Revenue of $3.0 million as of Q4 2021, which was down 5714.29% from $2.0 million recorded in Q3 2021.
- Chemours' 5-year Current Deferred Revenue high stood at $23.0 million for Q1 2017, and its period low was $2.0 million during Q3 2021.
- In the last 5 years, Chemours' Current Deferred Revenue had a median value of $7.0 million in 2019 and averaged $7.3 million.
- In the last 5 years, Chemours' Current Deferred Revenue crashed by 8947.37% in 2017 and then soared by 6000.0% in 2019.
- Over the past 5 years, Chemours' Current Deferred Revenue (Quarter) stood at $8.0 million in 2017, then dropped by 25.0% to $6.0 million in 2018, then grew by 16.67% to $7.0 million in 2019, then changed by 0.0% to $7.0 million in 2020, then plummeted by 57.14% to $3.0 million in 2021.
- Its Current Deferred Revenue stands at $3.0 million for Q4 2021, versus $2.0 million for Q3 2021 and $3.0 million for Q2 2021.